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INHIBITORY effect upon neutrophil migration to the inflam-
matory focus was previously detected in the cell-free
incubation fluid of lipopolysaccharide (LPS)-stimulated
macrophage monolayers. In the present study we showed
that the neutrophil recruitment inhibitory activity from
this supernatant was mainly detected in a fraction (P2)
obtained by gel filtration chromatography on Sephacryl
S-300. P2 fraction was able to inhibit ’in vivo’ neutrophil
emigration induced by different inflammatory stimuli, but
it did not affect ’in vitro" neutrophil chemotaxis induced
by FMLP. When injected intravenously, P2 inhibited
oedema induced by carrageenin or immunological stimu-
lus but not the oedema induced by dextran, thus affecting
cell-dependent inflammatory responses. It was observed
that P2 also induced neutrophil migration when injected
locally in peritoneal cavities. This activity was signific-
antly reduced by pretreatment of the animals with dex-
amethasone. Cytokines, such as IL-8 and TNF-g that are
known to exhibit inhibitory effect upon neutrophil mi-
gration, were not detected in P2 fraction by highly sensi-
tive assays. Overall the results suggest the existence of a
novel cytokine exhibiting ’in vivo" neutrophil inhibitory
activity, referred as NRIF.
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Introduction
Cytokines, such as IL-6, IL-8 and TNF-, besides
their pro-inflammatory effects
1-4 also exhibit anti-
inflammatory activities, such as inhibition of
neutrophil adhesion to activated endothelial cells
and ’in vivo’ inhibition of neutrophil migration into
inflammatory focus.
(-8 These cytokines are released
by various types of activated cells, such as those of
phagocyte mononuclear system,9’1 polymorpho-
nuclear leucocytes,
1 endothelial cells and T-
lymphocytes. 12’3
In our laboratory we have examined the activity
of supernatants from macrophage monolayers
stimulated with LPS. It was found that this crude
supernatant is able to induce neutrophil migration
when injected into peritoneal cavities of dex-
amethasone-pretreated rats. This activity was
referred as macrophage-derived neutrophil chemo-
tactic factor (MNCF).
.4 In contrast, neutrophil
migration to peritoneal cavities induced by
cytokines such as TNF-z and fl, IL-lz and
gamma interferon
16 and IL-8
7 are inhibited by
dexamethasone pretreatment. In addition, the same
supernatant when intravenously (i.v.) injected was
shown to inhibit in a dose dependent manner
neutrophil migration to an inflamed site.
8 The
factor responsible for this activity was named
neutrophil recruitment inhibitory factor (NRIF).
Therefore the objective of this study was to
characterize some biological properties of NRIF.
For this purpose, we have submitted crude
macrophage supernatant to gel filtration chroma-
tography obtaining a fraction (P2) that retained the
original inhibitory activity. We also observed that
the i.v. administration of P2 was able to block cell
dependent oedema. As IL-8 and TNF, cytokines for
which neutrophil recruitment inhibitory activity has
been described,<7 were not detected in P2 fraction,
that in addition was eluted far from the elution
volume expected for these cytokines, we suggest
that NRIF may constitute a novel cytokine.
Material and Methods
Animals" Adult male Wistar rats weighing 150-180 g
were housed in a temperature-controlled room and
received water and food ad libitum until use.
Immunization procedure: Animals were actively immu-
nized with 200/zg ovalbumin (OVA) emulsified in
50% complete Freund adjuvant (CFA) (DIFCO,
Detroit, MI, USA), by subcutaneous (s.c.) injection.
Controls received s.c. injections of CFA. Rats were
used in oedema paw assays on 28th day after
immunization.
Preparation of macrophage supernatant" The method for
obtaining NRIF by stimulating macrophage mono-
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layers has been described elsewhere. *s Briefly, the
peritoneal cavities of rats were stimulated by
injection of thioglycollate medium (DIFCO) (10 ml
of 3% thioglycollate medium/rat). Four days later,
the peritoneal cells were harvested with RPMI 1640
(Flow Laboratories, McLean, VG, USA) and
allowed to adhere in plastic tissue culture dishes for
1 h at 37C, in an atmosphere of air with 5% ofCO2.
The monolayers were then washed three times with
phosphate buffered saline (PBS, pH 7.4) and
incubated for 30 min at 37C with 10/tg m1-1 of
lipopolysaccharide of E. coli (LPS, 0111 :B4,
DIFCO). The supernatants were discarded and the
cells (95% macrophages) washed another three
more times with PBS, followed by a final 1 h
incubation with 5 ml of RPMI medium per dish, at
37C. The cell-free incubation fluids were sub-
sequently ultradiafiltered through an YM 10
membrane (Amicon Corp, Lexington, MA, USA).
The final volume (corresponding to 5% of the
original volume) was filtered on 0.22m membrane
(Millipore, Bedford, MA, USA).
Chromatographic procedure: One millilitre of macro-
phage supernatants prepared as described above,
containing the material released by 2.5 x 10
adherent cells, were dialysed against 0.5 M NaC1
solution buffered with 0.02 M phosphate pH 7.4,
and applied on Sephacryl S-300 column
(2.6 70 cm; Pharmacia, Uppsala, Sweden) at a
flow rate of 8 ml h -1. The S-300 column was
previously calibrated with a molecular weight
standards kit (Pierce Chemical Co., Rockford, IL,
USA) containing: ferritin (540KDa), catalase
(240 KDa), aldolase (158 KDa), BSA (67 KDa),
OVA (43 KDa), chemotrypsinogen (25 KDa) and
cytochrome c (12.4KDa). Blue dextran 2000
(Pharmacia) was used to determine the void volume
of the column. Absorbance at 280nm was
determined for each fraction collected (2ml
fractions). After desalting on a PD10 column
(Pharmacia), the fractions were pooled (Pool
1-Pool 10; three fractions/pool), starting with the
fraction corresponding to the void volume of the
column (fraction 23), and assayed for neutrophil
migration activities as described below.
In vitro neutrophil migration assay:
Preparation of human neutrophils. Viable and highly
purified preparation of human neutrophils were
obtained from heparinized venous blood of healthy
subjects by mono-poly-resolving medium (Flow
Laboratories, Irvine, Scotland) fractionation, ac-
cording to manufacturer’s instructions. Isolated
neutrophils were washed three times with RPMI
1640 medium and then resuspended in RPMI
medium containing 0.1% bovine serum albumin
(Sigma, St. Louis, MO, USA) (RPMI-BSA).
Pretreatment ofneutrophils. In order to determine if
S-300 chromatographic fractions presented ’in vitro’
inhibitory activity, neutrophil suspensions (106
cells/ml) were incubated for 30 min at 37C, in a
humidified incubator with 5% CO2, either in the
absence or in the presence of the pooled
chromatographic fractions of macrophage super-
natant, now referred as fractions P1 to P10, prior
to testing for chemotactic response to N-
formyl-methionyl-L-leucyl-L-phenylalanine (FMLP,
Sigma) in microchemotaxis assay. The chromato-
graphic fractions were diluted in RPMI-BSA in
order to give solutions containing the equivalent to
the product released by 107 adherent macro-
phages/ml and were present throughout the assay.
Chemotaxis assay. Chemotaxis was performed in
48-well chemotaxis chambers (Neuroprobe Inc.,
Cabin John, MD, USA). Polyvinylpirrolydone free
polycarbonate filters (0.5/.tm) (Millipore) were
placed between the upper and lower chambers.
Twenty-five #1 samples of either chemoattractant or
RPMI-BSA were added to the wells of the lower
chamber. FMLP was used at concentration of
5 x 10-8M in RPMI-BSA. Fifty #1 samples of
pretreated neutrophils were added to the wells of
the upper chamber. The chemotaxis chambers were
incubated for 1 h at 37C in 5% CO2. The cells
which have migrated to the lower side of the filter
were fixed and stained with Dill-Quick Stain Kit
(American Scientific Products, McGraw Park, IL).
Neutrophils were counted by using a 100 x objec-
tive in at least five random fields. Experiments were
performed in triplicate for each variable, and the
means determined. The results were expressed as
number of neutrophils per field. In each experiment,
untreated neutrophils migrating toward FMLP
were used as positive reference.
In vivo neutrophil migration assay:
Inhibition assay. Inhibition assays were performed
as described elsewhere. 18 Briefly, S-300 chromato-
graphic fractions (P1--P10 fractions) or different
amounts (3 pg-3 #g) of mouse recombinant TNF-
(mrTNF-z), which was a gift from Dr. M. A.
Palladino Jr. of the Cell Biology Department,
Genentech Inc., South San Francisco, CA, USA,
were i.v. injected into penial venous sinus of the
rats. Thirty min later, the animals received an
intraperitoneal (i.p.) injection of carrageenin
(300/.tg/3 ml) (Marine Colloids, Inc., USA), FMLP
solution (10
-7 M/3 ml) or LPS (5 ng/3 ml). Con-
trois received i.v. injections of PBS. Four hours
after i.p. injections, the rats were sacrificed in a CO2
chamber, their peritoneal cavities were washed with
10 ml of PBS containing 5 IU ml- of heparin and
total and differential cell counts in the lavage fluid
were performed as described elsewhere.
19 In
subsequent biological assays, 0.2 ml (equivalent to
the product released by 5 x 106 cells) of the fraction
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retaining maximal inhibitory activity was i.v.
injected per animal, except when indicated in the
Results section. The results are expressed as
means -+- SEM of the number of neutrophils per ml
of peritoneal wash.
Detection ofMNCF activity. The S-300 chromato-
graphic fractions were also assayed for the presence
of MNCF activity as described elsewhere. 14 Briefly,
the fractions were injected into peritoneal cavities
(3 ml/cavity, equivalent to the material released by
5 106 macrophages) of dexamethasone-pretreated
rats (0.5mgkg -1, s.c., 1 h before). Controls
received sterile saline both s.c. and i.p. injected.
After 4 h, neutrophil migration was measured as
indicated for inhibition assay.
TNF activity assay: TNF content in macrophage
supernatants and S-300 chromatographic fractions
was measured by using a highly TNF-sensitive cell
line, WEHI 164 clone 13, as described elsewhere.
2
WEHI 164 clone 13 was a gift from Dr. M. A.
Palladino Jr. (Genentech Inc, USA). Briefly, WEHI
cells were seeded in microplates (Costar 3596,
Cambridge, MA, USA) at concentrations of
4 104 cells/well in 50/,1 of growth medium
(RPMI 1640 medium) containing 10% foetal calf
serum (GIBCO). Fifty 1 of dilutions of crude
supernatant or S-300 chromatographic fractions
were added in triplicate to the cells. The plates were
incubated for an 20h, at 37C in a 5% CO2
incubator. Then, 10 #1 of a 3-4,5-dimethylthiazol-2-
yl-3,5-diphenylformazan solution (5 mg m1-1 PBS)
(MTT, Sigma) were added to each well and the
plates incubated for an additional 4 h. After that,
100/1 of isopropanol containing 0.04 N HC1 were
added to each well. Fifteen min later, the degree of
cell lysis was quantitated spectrophotometrically
(630 nm) by using an enzyme-linked immunoassay
analyser (Multiskan MCC/340 MKII, Flow Labor-
atories). Because of the unavailability of rat TNF,
standard curves were done with mrTNF-
(Genentech Inc.) and TNF content in assayed
materials were calculated by comparison with the
standard amounts. The results correspond to the
means of data obtained in at least three different
experiments. In some experiments, we use a rabbit
anti-mrTNF antibody to study the involvement of
TNF-like cytokine in our samples.
Measurement of rat paw oedema: Oedema was measured
plethysmographically.
2 The volume increase (A
volume) of the inflamed paw was obtained by
comparing the observed volume before and after
the intra-plantar (i.pl.) administration of 100
#g/0.1 ml of carrageenin, dextran (Dextran 70,
Pharmacia) or OVA. Animals were pretreated with
either sterile PBS or P2 chromatographic fraction
15 min before i.pl. challenge. Oedema was mea-
sured 2, 4 or 6 h after i.pl. challenge, except when
indicated.
Results
Neutrophil migration activities of S-300 chromatographic
fractions: The ’in vivo’ inhibitory activity displayed
by crude NRIF was detected in fraction P2 of S-300
chromatography of macrophage supernatants (Fig.
1, Panel A). The elution volume ofP2 corresponded
to an apparent molecular weight of 500 KDa.
When tested for TNF activity, crude supernatant
was demonstrated to contain significant amounts
(500 ng/0.2 ml), but only small amounts of such
cytokine (1 pg m1-1) were detected in P2 fraction.
Antibodies raised against mouse recombinant
TNF- abolished the cytotoxicity of the mrTNF-0
and strongly reduced the activity of the crude
supernatant (50-60% of inhibition). We have tested
increasing doses of mrTNF-0 (0.3 pg-3/g) upon
carrageenin-induced neutrophil migration. Only
TNF-0 doses 106 times greater than that found in
P2 were able to significantly inhibit neutrophil
migration to rat peritoneal cavities (data not
shown).
In panel B of Fig. 1, it is shown that P2 fraction
of S-300 chromatography did not inhibit ’in vitro’
chemotaxis induced by FMLP, while it was found
significant inhibition in fractions 5 to 10.
When chromatographic fractions were tested for
MNCF, the highest activity was eluted in the void
volume (P1) and in a fraction corresponding to
30-60 KDa (P7) (data not shown). In addition, we
have separately studied the effect of P2 injected into
peritoneal cavities. Figure 2 shows that P2 caused
neutrophil migration (left block of bars) that was
significantly reduced by pretreatment of the animals
with dexamethasone (right block of bars).
Besides its inhibitory effect upon neutrophil
migration induced by carrageenin, P2 fraction also
inhibited neutrophil recruitment induced by either
LPS or FMLP into rat peritoneal cavities (Fig. 3).
Eect of P2 fraction upon oedema: Figure 4 shows that
P2 fraction inhibited carrageenin (left group of
bars) but not the oedema induced by dextran (right
group of bars), as measured 2 h after inflammatory
stimuli. The Fig. 5 shows that P2 fraction injected
before ovalbumin challenge reduced the oedema
(full and open circles) but did not aflect the paw
volume of control animals previously treated with
CFA only (open and full squares).
Discussion
Previous work from our laboratory have
indicated the presence of a neutrophil recruitment
inhibitory activity in thioglycollate-elicited and
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FIG. 1. Effect of S-300 chromatographic fractions on neutrophil migration and chemotaxis. Panel
A shows neutrophil migrations induced by i.p. injection of carrageenin (300 #g/rat) in animals
pretreated 15 min before with i.v. injections of PBS (C, control), S-300 chromatographic
fractions (P1-P10) or crude supernatant (NRIF), as indicated in Material and Methods. Traced
line (--O-O-) represents the absorbance of each fraction (280 nm), starting with fraction 20.
The results are reported as means SEM of six animals per experimental group.* p < 0.01 and
**p < 0.05 as compared to control group. Panel B shows the effect of the pretreatment of human
neutrophils with S-300 fractions on chemotaxis induced by FMLP (5 x 10-8 M). The results
are expressed as means_+ SEM of cells counted in 15 microscopic fields. *p< 0.01 and
**p < 0.05 as compared to control group. Student’s t-test.
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FIG. 2. Detection of MNCF activity in P2 fraction. The bars represent
neutrophil migration into peritoneal cavities induced by either saline (C,
control) or P2 fraction, in either saline or dexamethasone (0.5 mg kg -1,
s.c., h before) pretreated animals. The results are reported as
means -I- SEM of the number of animals indicated up each bar. *p < 0.01
as compared to control. Student’s t-test.
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FIG. 3. Inhibitory effect of P2 fraction upon neutrophil migration induced
by different inflammatory stimuli. Bars represent neutrophil migrations
induced by i.p. injections of carrageenin (Cg, 300 #g), LPS (5 ng) or
FMLP (130 ng), in animals pretreated with i.v. injection of P2 fraction.
The results are reported as means___ SEM of the number of animals
indicated up each bar. *p < 0.05 as compared to control group. Student’s
t-test.
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FIG. 4. Inhibitory effect of P2 fraction on carrageenin-induced oedema.
The bars show the increase in volume induced by 100 #g i.pl. injection
of either carrageenin (Cg) or dextran (DEX) in animals pretreated 15 min
before with i.v. injection of either PBS" (C, control) or P2 fraction (P2).
Oedema was measured 4 h after challenge. The .results are reported as
the means +__ SEM of five animals per experimental group. *p < 0.01 as
compared to controls. Student’s t-test.
LPS-stimulated macrophage supernatants.
18 This
activity was referred to as neutrophil recruitment
inhibitory factor (NRIF), since it was specific for
polymorphonuclear leucocytes and in contrast with
other substances, such as LPS, it did not inhibit
mononuclear cell migration to rat peritoneal
cavities.
22 This result indicates that NRIF is not
contaminated with LPS. Further evidence that
NRIF activity is not due to LPS contamination is
based upon the fact that polymyxin B did not affect
NRIF activity but abolished LPS neutrophil
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FIG. 5. Inhibitory effect of P2 fraction on immunologically-induced
oedema. Immunization procedure was performed with OVA + CFA
(circles) or with CFA only (squares). On day of experiment, rats were
pretreated 15 min before with i.v. injection of either PBS (C, control) or
P2 fraction (P2) and challenged with 100/g i.pl. injection of OVA.
Oedema was measured 2, 4 and 6 h. The results are expressed as
indicated in Fig. 4. *p < 0.05 as compared to control. Student’s t-test.
recruitment inhibitory eEect.
18 Furthermore, re-
sident macrophage monolayers release the same
inhibitory activity without LPS stimulation.
23 In the
present study we showed that NRIF activity was
present in a fraction, referred as P2, obtained by gel
filtration chromatography of the crude macrophage
supernatant on Sephacryl S-300. This fraction was
eluted in a volume corresponding to high molecular
weight proteins (240-550 KDa) as deduced by
standard calibration curve.
P2 fraction was effective against other in-
flammatory stimuli than carrageenin, such as EPS or
FMLP, the latter being a direct chemotactic
attractant
24 in ’in vivo’ inhibitory assays. In contrast,
P2 fraction did not inhibit neutrophil chemotaxis
induced by FMLP in microchemotaxis assay. These
results taken together, suggest that NRIF did not
affect the ability of neutrophils to respond to
chemotactic stimuli, thus supporting the suggestion
that NRIF may be acting by blocking neutrophil-
endothelial adhesion mechanisms.
18 However, addi-
tional experiments with more purified material are
required to clarify its precise mechanism of action.
Similar to NRIF, i.v. administration of TNF-0
has been shown to inhibit neutrophil accumulation
at the site of inflammatory stimulus injection. Our
results showed that crude macrophage supernatants
contain significant TNF amounts (blocked by
rabbit anti-mrTNF antibodies) that may contribute
to inhibitory activity displayed by this material.
However, P2 fraction presented only traces ofTNF,
corresponding to a quantity 10 times slower than
that necessary to present neutrophil recruitment
inhibitory activity. Circumstantial evidence that
NRIF inhibitory activity is not due to TNF is
supported by the high apparent molecular weight
of the P2 fraction.
IL-8 is another cytokine presently shown to
inhibit neutrophil accumulation at sites of acute
inflammation when administered intravenously.
The possibility that NRIF activity may be
contaminated by IL-8 is minimized by its high
molecular weight elution volume and by the
evidence that no traces of IL-8 was found in a
sample of P2 fraction (ELISA, using a monoclonal
antibody raised against human recombinant IL-8,
sensitivity of detection smaller than 50 pg, see
acknowledgements). It should be pointed out,
however, that the absence of detection could be due
to the low sensitivity of the test to rat IL-8.
However, in an on going experiment in our
laboratory, it was found that antibodies raised
against human IL-8 are able to inhibit either
carrageenin as well as hlL-8-induced hyperalgesia
in the rat.
Previous results obtained in our laboratory
showed the presence of IL-1 in crude supernatant
of LPS-stimulated macrophages.
18 However, as
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demonstrated by the authors, IL-1 does not block
neutrophil migration to peritoneal cavities even if
it is injected in doses higher than those detected in
such supernatants.
Another inflammatory parameter, rat paw
oedema induced by either carrageenin or antigen
challenge, was significantly reduced by P2 fraction
administration. This effect was not observed with
dextran-induced oedema. Carrageenin and dextrans
have been shown to induce increased vascular
permeability by different mechanisms. While
dextrans induce fluid accumulation due to mast cell
degranulation with little protein and few neu-
trophils, carrageenin induces a protein-rich exudate
containing large number of neutrophils.
25 Since
NRIF did not present inhibitory activity upon
dextran-induced oedema, we suggest that the factor
only acts in polymorphonuclear-leucocyte de-
pendent inflammatory responses. Thus, it is
plausible that P2 is blocking immunologically-
induced oedema by a similar mechanism. If this
hypothesis is correct, we can envisage its usefulness
in the control of immunological diseases such
as bronchial asthma, where infiltration of
inflammatory cells has been related to bronchial
hyperresponsiveness.
26 Further evidence that NRIF
activity is not due to IL-1 or TNF presence
has been demonstrated by the results that i.v.
injected rh-IL1 ( and fl) and TNF-o inhibit both
carrageenin and dextran-induced oedema. 27
Several cytokines, including TNF-o and fl, ILl-o
and /,15 gamma interferon
16 and IL-817’28 are
reported to induce neutrophil migration. In
contrast to MNCF, dexamethasone inhibited the
activity of those known cytokines.
1>17 We have
observed that ’in vivo’ chemotactic activity displayed
by P2 was significantly blocked by pretreatment of
the animals with dexamethasone, thus indicating
that there is a material which indirectly stimulates
neutrophil emigration. This activity could result
from the presence of traces of several cytokines or
due to NRIF by itself. The residual emigration
induced by P2 in rats pretreated with dexa-
methasone may result from the presence of a direct
acting cytokine, such as MNCF since this activity
was eluted in two peaks, one of them corresponding
to the void volume fraction, eluted just before P2.
Further studies are necessary to clarify this point.
In the light of the present results it is possible to
assume NRIF as a candidate for a novel cytokine,
capable of inhibiting neutrophil migration to an
inflammatory site when present in the circulation,
as might occur in endotoxemic shock.
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